Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Abzena: $10m Growth Investment from Biospring Partners (2020-07-28)
Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based in...
Enthera Raises €28m Series A Co-led by Sofinnova & AbbVie (2020-07-28)
Enthera Pharmaceuticals (“Enthera”), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the completion ...
Polyphor & IRIS: CHF19.3m Equity-linked Financing (2020-07-28)
Polyphor AG (SIX: POLN) today announced that it has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over the period of two years. IRIS will receive Polyphor shares to be created from...
4basebio AG Informs about Takeover Bid by Sparta AG (2020-07-28)
4basebio AG (Frankfurt: 4BSB; ISIN: DE000A2YN801; Prime Standard) announces that its investor Sparta AG intends to submit a takeover bid for the company’s shares. According to an announcement Sparta published on July 27, 2020, Sparta has decided to make a voluntary...
BioNTech Closes $512m Underwritten Offering of ADSs (2020-07-27)
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the closing of its previously announced underwritten offering (the “Underwritten Offering”) of 5,500,000 American Depositary Shares (“ADSs”), each representing one of its ordinary shares, at a ...
iTeos Therapeutics Prices $201m IPO at Nasdaq Global Market (2020-07-23)
iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced the pricing of its initial public of...
Vesigen Therapeutics Launches with $28.5m Series A Round (2020-07-22)
> Investment addresses today’s challenge to efficiently transport next-generation therapeutics such as cell and gene therapy to the target and unlock their full potential as innovative therapies for patients > Vesigen’s ARMMs technology enables translation of n...
T3 Pharma Raises CHF25m to Advance Bacterial Cancer Therapy (2020-07-22)
Proceeds will support clinical development of lead program, T3P-Y058-739, poised to enter clinical trials in 2021 T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, today announce...
BioNTech & Pfizer & US Govt: up to 600m Covid Vaccine Doses (2020-07-22)
> U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional doses > Americans to receive the vaccine for free consistent with U.S. government’s commitment for free access for COVID-19 vaccines ...
Tubulis Raises €10.7m Series A Round to Develop ADCs (2020-07-21)
Tubulis today announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates (ADCs) and to support the further growth of the company. The financing round was co-le...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]